Glucagon-like peptide-1 (GLP-1) agonists, employed to treat diabetes and obesity, has been tested on MASH patients and is widely regarded as the preferred treatment for MASH
Filter-sterilize through a 0.22 m low-protein-binding filter before adding to sterile cultures
Because of new emerging research on the synergistic benefits of selenium with myo-inositol, because I know its easier to take one supplement instead of multiple supplements per day, and because some of my more sensitive readers were reporting side effects with even 200 mcg of selenium when used as a standalone dose, I was excited to create a new supplement that combines selenium and myo-inositol in the same exact doses that were studied by researchers
While GHK-Cu has a strong safety record and compelling mechanistic data, most of the clinical evidence remains in the early-to-moderate phase
[1] Clinical trials of liraglutide for weight management, as documented in the European Medicines Agency's assessment report, have not identified fibroids as a treatment-related complication